Literature DB >> 20298130

Maternal laboratory stress influences fetal neurobehavior: cortisol does not provide all answers.

Nadine Stephanie Fink1, Corinne Urech, Christoph Tobias Berger, Irene Hoesli, Wolfgang Holzgreve, Johannes Bitzer, Judith Alder.   

Abstract

OBJECTIVE: Maternal stress can have an impact on pregnancy. However, effects on fetal neurobehavior are not well understood. In this study, the effect of laboratory stress on maternal psychoneuroendocrinological response and on fetal neurobehavior was studied. Serum cortisol as a potential underlying mechanism was measured.
METHODS: Twenty-seven women made a single 1.5-h visit in their third trimester. The laboratory stressor involved an arithmetic task. Associations between maternal laboratory stress response and fetal neurobehavior were analyzed by studying 19 maternal-fetal dyads with high signal quality cardiotocograms.
RESULTS: Stress exposure changed participants stress perception (p < 0.0001). However, only half of the participants (responders) had an HPA-axis response. Fetuses responded to the stress exposure depending on their mothers' stress response: (i) there was a fetal heart rate (FHR) group effect at the level of trend (p = 0.06). Fetuses of responders had higher HR levels 20 min after the exposure (p = 0.043), (ii) there were interaction (p = 0.026) and group effects at the level of trend (p = 0.078) found for FHR short-term variation (STV). Fetuses of responders had lower FHR STV 20 min after stress exposure (p = 0.007). Cortisol as a potential underlying mechanism only seemed to be associated with short- and long-term variation of FHR.
CONCLUSIONS: An activation of the maternal stress-system could result in a child being born having a history of responding to maternal stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20298130     DOI: 10.3109/14767050903300985

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  8 in total

1.  STUDIES IN FETAL BEHAVIOR: REVISITED, RENEWED, AND REIMAGINED.

Authors:  Janet A DiPietro; Kathleen A Costigan; Kristin M Voegtline
Journal:  Monogr Soc Res Child Dev       Date:  2015-09

2.  Mood disorders and their pharmacological treatment during pregnancy: is the future child affected?

Authors:  Catherine Monk; Elizabeth M Fitelson; Elizabeth Werner
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

3.  Physiological reactivity of pregnant women to evoked fetal startle.

Authors:  Janet A DiPietro; Kristin M Voegtline; Kathleen A Costigan; Frank Aguirre; Katie Kivlighan; Ping Chen
Journal:  J Psychosom Res       Date:  2013-08-05       Impact factor: 3.006

Review 4.  Mechanisms underlying the effects of prenatal psychosocial stress on child outcomes: beyond the HPA axis.

Authors:  Roseriet Beijers; Jan K Buitelaar; Carolina de Weerth
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-05-30       Impact factor: 4.785

5.  Pregnancy distress gets under fetal skin: Maternal ambulatory assessment & sex differences in prenatal development.

Authors:  Colleen Doyle; Elizabeth Werner; Tianshu Feng; Seonjoo Lee; Margaret Altemus; Joseph R Isler; Catherine Monk
Journal:  Dev Psychobiol       Date:  2015-05-06       Impact factor: 3.038

6.  Full-term-pregnancy effects of antenatal betamethasone administration on short-term variation as assessed by computerized cardiotocography.

Authors:  Juan Piazze; Kathleen Comalli Dillon; Cerekja Albana
Journal:  J Prenat Med       Date:  2012-04

7.  Concurrent levels of maternal salivary cortisol are unrelated to self-reported psychological measures in low-risk pregnant women.

Authors:  Kristin M Voegtline; Kathleen A Costigan; Katie T Kivlighan; Mark L Laudenslager; Janice L Henderson; Janet A DiPietro
Journal:  Arch Womens Ment Health       Date:  2012-12-27       Impact factor: 3.633

8.  Early Biomarkers and Intervention Programs for the Infant Exposed to Prenatal Stress.

Authors:  Marta C Antonelli; Martin G Frasch; Mercedes Rumi; Ritika Sharma; Peter Zimmermann; Maria S Molinet; Silvia M Lobmaier
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.